Overview

Determine the Effects of Gene Differences and Voriconazole on Enzyme CYP2B6 Activity in the Liver in Healthy Volunteers

Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if administration of medicines and genetic differences affects the activity of a liver enzyme called CYP2B6 in healthy volunteers.
Phase:
N/A
Details
Lead Sponsor:
Indiana University
Collaborators:
National Institute of General Medical Sciences (NIGMS)
National Institutes of Health (NIH)
Treatments:
Efavirenz
Voriconazole